O-1602
O-1602 is a novel GPR55 agonist, an atypical cannabinoid associated with the central nervous system and obesity, and is a candidate compound for the treatment of cystitis.O-1602 promotes hepatic steatosis through GPR55 and PI3 kinase / Akt / SREBP-1c signalling in mice.O-1602 induces, in a GPR3-independent manner, in Hep55B cells with elevated intracellular calcium.
Product Specifications
CAS Number
317321-41-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
258.36
Molecular Formula
C17H22O2
Notes
Research use only, not for human use.
Receptor
Calcium Channel | Cannabinoid Receptor
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog